Valuation: Consort Medical plc

Market Cap 502M 435M 405M 373M 704M 47.73B 711M 4.76B 1.87B 23.88B 1.89B 1.84B 79.09B P/E 2018
36.7x
P/E 2019 43.5x
Enterprise Value 599M 519M 484M 445M 840M 56.99B 850M 5.69B 2.23B 28.51B 2.25B 2.2B 94.43B EV / Sales 2018
2.2x
EV / Sales 2019 1.8x
Free-Float
-
Yield 2018
1.75%
Yield 2019 2.32%
Director TitleAgeSince
Director/Board Member 46 2023-01-31
Director/Board Member 52 2024-03-31
Director/Board Member 53 2024-03-31
Date Insider Type Main position Quantity % Market Cap.
2/6/20 Sell 211,474 0.4284%
2/6/20 Fiscal year 211,474 0.4284%
2/6/20 Sell 467 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+0.50% - - 628M
+0.24%-2.12%-19.11%-1.80% 182B
-0.24%-1.77%-4.10%+2.32% 110B
+3.57%-0.44%+8.51%+71.16% 59.59B
-2.32%+6.21%+35.55%+51.53% 55.04B
+0.32%+1.34%-3.52%-36.98% 46.87B
-12.79%-8.52% - - 35.55B
-4.92%+10.01%+9.54%-31.31% 32.81B
+0.65%+4.02%+46.96%-6.41% 24.54B
-0.06%-0.90%+3.95%+2.96% 22.69B
Average -1.55%+1.36%+9.72%+6.43% 57.06B
Weighted average by Cap. -0.84%+0.22%-0.16%+7.77%

Financials

2018 2019
Net sales 311M 269M 251M 231M 436M 29.58B 441M 2.95B 1.16B 14.8B 1.17B 1.14B 49.02B 305M 264M 246M 227M 428M 29.01B 432M 2.89B 1.14B 14.52B 1.15B 1.12B 48.07B
Net income 16.1M 13.94M 13M 11.96M 22.57M 1.53B 22.82M 153M 59.95M 766M 60.47M 59.14M 2.54B 10.5M 9.09M 8.48M 7.8M 14.72M 998M 14.88M 99.62M 39.1M 500M 39.44M 38.57M 1.65B
Net Debt 95.5M 82.71M 77.1M 70.91M 134M 9.08B 135M 906M 356M 4.54B 359M 351M 15.05B 97.4M 84.36M 78.64M 72.33M 137M 9.26B 138M 924M 363M 4.63B 366M 358M 15.35B
Logo Consort Medical plc
Consort Medical PLC is a United kingdom-based company that operates as a holding company. The Company wit its subsidiaries engaged in contract development and manufacturing organization (CDMO). The Company's services include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences.
Employees
-
  1. Stock Market
  2. Stocks
  3. CSRT Stock